InvestorsHub Logo
Followers 239
Posts 12059
Boards Moderated 0
Alias Born 08/14/2003

Re: None

Friday, 10/18/2019 2:34:55 PM

Friday, October 18, 2019 2:34:55 PM

Post# of 44784
I believe people aren't looking at the share price in the manner it ought to be, that's the Market Cap. If trial results are released suggest one or more product is headed for approval, what would be a fair market cap for the company. Likewise, if they received a substantial order from the DOD prior to full FDA approval.

Depending on the news, I believe anything that's quite positive should lead to at least a half billion dollar market cap. If by the time this occurs our shares outstanding grow to say 20 million, that's a $25 share price.

Of course if the news is better than I suggest, a billion dollar or bigger market cap is possible, and certainly if it takes substantial time more than 20 million shares are probable. The key is, what's in the news, and how quickly it occurs.

I believe the DOD has assisted PSTI financially in developing it's product for radiation. In that situation, I believe the DOD will be able to purchase the product at a substantial reduction to the list price. That's not to say it won't be profitable to get the order, but others will pay more for the drug when they purchase it in the future. Perhaps the best news with this drug is that it appears to have many applications that go beyond just radiation, so the potential appears to be growing dramatically with each added application.

Gary